86827-10-3 Usage
Uses
Used in Pharmaceutical Industry:
N-Cbz-3-piperidineacetic acid is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs. Its structural properties allow for the creation of molecules with potential therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical sector, N-Cbz-3-piperidineacetic acid is utilized as an intermediate in the production of agrochemicals, helping to develop compounds that can protect crops and enhance agricultural productivity.
Used in Organic Chemical Synthesis:
N-Cbz-3-piperidineacetic acid is employed as a building block in organic chemical synthesis, providing a foundation for creating a diverse range of chemical compounds for various applications.
Used in Drug Discovery and Development:
N-Cbz-3-piperidineacetic acid plays a significant role in drug discovery and development, where it is used to construct bioactive molecules that can be further optimized for specific medical indications.
It is crucial to handle N-Cbz-3-piperidineacetic acid with care and follow proper safety protocols when used in laboratory settings to ensure the safety of both the researchers and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 86827-10-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,6,8,2 and 7 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 86827-10:
(7*8)+(6*6)+(5*8)+(4*2)+(3*7)+(2*1)+(1*0)=163
163 % 10 = 3
So 86827-10-3 is a valid CAS Registry Number.
InChI:InChI=1/C15H19NO4/c17-14(18)9-13-7-4-8-16(10-13)15(19)20-11-12-5-2-1-3-6-12/h1-3,5-6,13H,4,7-11H2,(H,17,18)
86827-10-3Relevant articles and documents
HETEROCYCLIC THROMBIN INHIBITORS
-
, (2008/06/13)
Heterocyclic thrombin inhibitors are provided which have the structure STR1 wherein n, R, R 1, R 2, R 3, G, G x, R. sup.6', Ra, Xa, R 6, Rb, R 3, p, Q, A and R 4 are as defined herein.